Post-Traumatic Stress Disorder Clinical Trial
Official title:
Trauma Management Therapy for OEF and OIF Combat Veterans
This trial will evaluate the efficacy and efficiency of Trauma Management Therapy (TMT; Frueh, Turner, Beidel, 1996; Beidel, Frueh, Uhde, under preparation), which combines individual virtual reality (VR) assisted exposure therapy with group social and emotional rehabilitation skills training (will be superior to a treatment consisting of the same VR- exposure and group psychoeducational group therapy. TMT will be conducted in traditional 17-week format, and a 3-week intensive treatment format. Outcome will be assessed using relevant clinical, process, and cost outcomes. Additionally, investigators will assess the potential of olfactory stimulation as a trigger for PTSD symptoms of intrusive thoughts and re-experiencing. Therefore, this proposal will integrate clinical and neurobiological assessment studies designed to understand the role of these factors in the etiology, maintenance, and treatment of PTSD.
Background: Troop deployment for OIF/OEF has been extensive for the past five years Among
returning veterans, up to 18.5% are diagnosed with posttraumatic stress disorder (PTSD). In
addition to its positive symptoms (intrusive thoughts, reexperiencing, hyperarousal, and
avoidance), PTSD is associated with social maladjustment, poor quality of life, medical
comorbidity, and general symptom severity. Social and emotional problems include social
avoidance, guilt, anger, and unemployment, impulsive or violent behavior, and family discord.
A majority (> 90%) of veterans seeking treatment for PTSD also seek disability compensation
for debilitating occupational impairment and there are virtually no administrative or
research data to indicate veterans are recovering from PTSD. Exposure therapy, which operates
on long-established and fundamental principles of behavior therapy, offers hope for acute
symptom alleviation, but may not address severe social impairment.
Objectives/Hypothesis: To test the hypothesis that Trauma Management Therapy (TMT), which
combines individual virtual reality (VR) assisted exposure therapy with group social and
emotional rehabilitation skills training (will be superior to a treatment consisting of the
same VR- exposure and group psychoeducational group therapy. Outcome will be assessed using
relevant clinical, process, and cost outcomes. Additionally, we will assess the potential of
olfactory stimulation as a trigger for PTSD symptoms of intrusive thoughts and
re-experiencing. Therefore, this proposal will integrate clinical and neurobiological
assessment studies designed to understand the role of these factors in the etiology,
maintenance, and treatment of PTSD.
Specific Aims: There are three specific aims: First, we will evaluate the efficacy of Trauma
Management Therapy (TMT) for the treatment of PTSD in OIF/OEF and determine if TMT (which
combines exposure and social/emotional rehabilitation) improves social/emotional functioning
compared to our comparison group (exposure plus psychoeducational group therapy). Second, we
will explore olfactory activation patterns that may aid understanding of brain mechanisms in
PTSD. Third, we will determine TMT's cost efficacy using treatment expenses and resource
utilization measures.
Study Design: In a prospective randomized clinical trial we will test the superiority of TMT
for OIF/OEF veterans with PTSD compared to exposure therapy plus psychoeducational group
therapy. TMT combines VR assisted exposure therapy (VR-EXP) with social and emotional
rehabilitation (SER). In addition to clinical, process, and cost outcomes relevant to PTSD
for this population, we will include fMRI assessment of the central olfactory system in order
to document its hypothesized role in fear acquisition and maintenance. Relevant outcome
domains will be reassessed at mid-treatment, post-treatment, and 3- and 6-month follow-up.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04317820 -
Deep Brain Reorienting in Post-traumatic Stress Disorder
|
N/A | |
Completed |
NCT05112003 -
Translingual Neurostimulation for the Virtual Treatment of Post-Traumatic Stress Disorder: A Feasibility Pilot
|
N/A | |
Recruiting |
NCT04518267 -
Anger and Psychotrauma: Data From Military and Civilians
|
||
Completed |
NCT02502604 -
Cognitive Training Program for Individuals With Depression and Post-Traumatic Stress Disorder
|
N/A | |
Terminated |
NCT02234687 -
A mGlu2/3 Agonist in the Treatment of PTSD
|
Phase 1 | |
Completed |
NCT02256566 -
Cognitive Training for Mood and Anxiety Disorders
|
N/A | |
Completed |
NCT01738308 -
The Effects of Healing Touch on Post Operative Pediatric Patients
|
N/A | |
Terminated |
NCT02520726 -
PTSD Prevention Study Examining the Efficacy of Sertraline in Burn Victims
|
Phase 4 | |
Completed |
NCT02213900 -
Preventing Post-Operative Delirium in Patients Undergoing a Pneumonectomy, Esophagectomy or Thoracotomy
|
Phase 4 | |
Completed |
NCT01437891 -
Sentra AM® and Sentra PM® for Post-traumatic Stress Disorder (PTSD) and Gulf War Fibromyalgia (GWF)
|
N/A | |
Completed |
NCT01517711 -
Tramadol Extended-Release (ER) for Posttraumatic Stress Disorder (PTSD)
|
Phase 4 | |
Completed |
NCT01998100 -
Maximizing Treatment Outcome in Post-Traumatic Stress Disorder (PTSD)
|
Phase 3 | |
Completed |
NCT01199107 -
Maximizing Treatment Outcome and Examining Sleep in Post-traumatic Stress Disorder (PTSD)
|
Phase 3 | |
Completed |
NCT01231711 -
Improving Quality-of-life and Depressive Symptoms of Combat Veterans Via Internet-based Intervention
|
Phase 1 | |
Completed |
NCT00348036 -
Group Intervention for Interpersonal Trauma
|
N/A | |
Completed |
NCT00838006 -
Psychophysiologic Predictors of Post-deployment Mental Health Outcomes
|
N/A | |
Completed |
NCT00680524 -
Telephone-based Care for OEF/OIF Veterans With PTSD
|
N/A | |
Completed |
NCT00525226 -
Evaluating the Effects of Stress in Pregnancy
|
N/A | |
Completed |
NCT00183690 -
Prolonged Exposure Therapy Versus Active Psychotherapy in Treating Post-Traumatic Stress Disorder in Adolescents
|
Phase 1 | |
Completed |
NCT00158262 -
Effect of Propranolol on Preventing Posttraumatic Stress Disorder
|
Phase 4 |